Dashboard
Manage Tickers

MRNAModerna, Inc.

Nasdaq modernatx.com


$ 124.94 $ -0.65 (-0.52 %)    

Friday, 03-May-2024 15:59:48 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 435.98 $ 3.66 (0.85 %)
DIA $ 386.87 $ 0.13 (0.03 %)
SPY $ 511.25 $ 6.22 (1.23 %)
TLT $ 89.88 $ -0.23 (-0.26 %)
GLD $ 212.97 $ -0.45 (-0.21 %)
$ 125
$ 124.04
$ 0.00 x 0
$ 0.00 x 0
$ 122.05 - $ 126.05
$ 62.55 - $ 142.79
11,973,082
na
47.98B
$ 0.35
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-02-2024 03-31-2024 10-Q
2 02-23-2024 12-31-2023 10-K
3 11-03-2023 09-30-2023 10-Q
4 08-03-2023 06-30-2023 10-Q
5 05-04-2023 03-31-2023 10-Q
6 02-24-2023 12-31-2022 10-K
7 11-03-2022 09-30-2022 10-Q
8 08-03-2022 06-30-2022 10-Q
9 05-04-2022 03-31-2022 10-Q
10 02-25-2022 12-31-2021 10-K
11 11-04-2021 09-30-2021 10-Q
12 08-05-2021 06-30-2021 10-Q
13 05-06-2021 03-31-2021 10-Q
14 02-26-2021 12-31-2020 10-K
15 10-30-2020 09-30-2020 10-Q
16 08-06-2020 06-30-2020 10-Q
17 05-07-2020 03-31-2020 10-Q
18 02-27-2020 12-31-2019 10-K
19 11-06-2019 09-30-2019 10-Q
20 08-08-2019 06-30-2019 10-Q
21 05-09-2019 03-31-2019 10-Q
22 03-13-2019 12-31-2018 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

rbc-capital-maintains-outperform-on-moderna-raises-price-target-to-135
RBC Capital Maintains Outperform on Modern...
05/03/2024 16:59:03

RBC Capital analyst Luca Issi maintains Moderna (NASDAQ:MRNA) with a Outperform and raises the price target from $125 to $135.

navigating-6-analyst-ratings-for-moderna
Navigating 6 Analyst Ratings For Moderna
05/03/2024 15:00:42

oppenheimer-maintains-outperform-on-moderna-raises-price-target-to-163
Oppenheimer Maintains Outperform on Modern...
05/03/2024 13:10:18

Oppenheimer analyst Hartaj Singh maintains Moderna (NASDAQ:MRNA) with a Outperform and raises the price target from $142 to ...

wall-street-inches-up-after-powells-inflation-remarks-chipmakers-rebound-gold-crude-falter-whats-driving-markets-thursday
Wall Street Inches Up After Powell's Infla...
05/02/2024 17:37:33

U.S. stock markets surged during Thursday’s midday trading session in New York, with major averages all showing gains.

10-health-care-stocks-whale-activity-in-todays-session
10 Health Care Stocks Whale Activity In To...
05/02/2024 17:35:24

needham-reiterates-hold-on-moderna
Needham Reiterates Hold on Moderna
05/02/2024 17:18:32

Needham analyst Joseph Stringer reiterates Moderna (NASDAQ:MRNA) with a Hold.

moderna-reports-smaller-than-expected-q1-loss-prepares-for-rsv-vaccine-and-spikevax-2024-2025-formula-stock-soars
Moderna Reports Smaller Than Expected Q1 L...
05/02/2024 17:12:43

Moderna reports Q1 loss, beating sales estimates amidst declining COVID-19 vaccine demand. Cost-saving measures drive optimism ...

merck-reports-progress-on-the-cancer-front-as-it-prepares-for-keytruda-patent-expiration
Merck Reports Progress On The Cancer Front...
05/02/2024 16:53:54

After topping expectations with first quarter revenue and adjusted earnings last week, Merck & Co Inc (NYSE: MRK) just repo...

ch-robinson-worldwide-posts-upbeat-results-joins-avis-budget-group-qualcomm-borgwarner-moderna-and-other-big-stocks-moving-higher-on-thursday
C.H. Robinson Worldwide Posts Upbeat Resul...
05/02/2024 14:28:29

nasdaq-sp-500-futures-rise-ahead-of-apple-earnings-why-this-analyst-thinks-no-cut-scenario-may-not-be-negative-for-market
Nasdaq, S&P 500 Futures Rise Ahead Of Appl...
05/02/2024 10:52:51

U.S. stocks look to push ahead on a positive path, now that the Federal Reserve’s rate decision is in the rearview mirror. Majo...

moderna-reaffirms-its-2024-expected-revenue-of-approximately-4b-versus-consensus-of-421b-from-its-respiratory-franchise-and-now-expects-approximately-03b-in-net-sales-in-1h-2024-reflecting-the-seasonality-of-the-respiratory-business
Moderna Reaffirms Its 2024 Expected Revenu...
05/02/2024 10:37:56

moderna-q1-2024-gaap-eps-307-beats-355-estimate-sales-167000m-beat-97501m-estimate
Moderna Q1 2024 GAAP EPS $(3.07) Beats $(3...
05/02/2024 10:34:25

Moderna (NASDAQ:MRNA) reported quarterly losses of $(3.07) per share which beat the analyst consensus estimate of $(3.55) by 13...

1000-invested-in-this-stock-5-years-ago-would-be-worth-4100-today
$1000 Invested In This Stock 5 Years Ago W...
05/01/2024 21:30:34

smart-money-is-betting-big-in-mrna-options
Smart Money Is Betting Big In MRNA Options
04/30/2024 17:15:58

mrna-is-promising-a-breakthrough-in-fighting-cancer
mRNA Is Promising A Breakthrough In Fighti...
04/29/2024 14:02:43

When it comes to cancer, there’s innovation both on the diagnostics and the treatment front thanks to messenger RNA, or mRNA, a...

reported-earlier-moderna-out-licenses-covid-19-patents-in-japan-secures-royalty-on-sales-financial-terms-undisclosed
Reported Earlier, Moderna Out-Licenses COV...
04/29/2024 11:18:25

Moderna non-exclusively out-licenses COVID-19-related patents for the territory of Japan Moderna to receive upfront payment ...

will-earnings-cheer-continue-to-buoy-markets-apple-amazon-pfizer-coinbase-lead-flurry-of-q1-reports-this-week
Will Earnings Cheer Continue To Buoy Marke...
04/29/2024 05:51:21

With the earnings season now halfway through, the percentage of S&P 500 companies reporting positive earnings surprises and...

whats-going-on-with-pfizer-stock-on-thursday
What's Going On With Pfizer Stock On Thurs...
04/25/2024 17:51:32

GSK initiates legal proceedings against Pfizer and BioNTech over alleged COVID-19 vaccine patent infringement, intensifying hig...

how-is-the-market-feeling-about-moderna
How Is The Market Feeling About Moderna?
04/25/2024 13:45:21

moderna-to-present-data-from-its-respiratory-portfolio-including-vaccines-and-vaccine-candidates-and-cytomegalovirus-research-at-escmid-global-congress
Moderna To Present Data From Its Respirato...
04/25/2024 11:37:40

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION